Respiratory rate patient monitor market was valued at $16.8 billion in 2025 and is projected to reach $38.8 billion by 2035, growing at a CAGR of 8.9% during the forecast Period (2026-2035). FDA clearance of advanced respiratory monitoring technologies enhances safety, accuracy, and reliability confidence, promoting market penetration and investment in connected health devices, thereby driving market growth. For instance, in April 2025, Makani Science received 510(k) clearance from the FDA for its Makani Respiratory Monitor, a wearable device designed for continuous real-time monitoring of respiratory rates. This clearance demonstrates the device's patient safety, accuracy, and reliability, following extensive testing in various clinical settings. Unlike traditional monitors, its wire-free, comfortable design allows ambulatory individuals to access respiratory performance data on iOS devices instantly. The approval enables Makani Science to proceed with manufacturing and clinical deployments, targeting applications in hospitals, outpatient clinics, and athletic settings, where non-invasive monitoring can be beneficial.
Browse the full report description of “Respiratory Rate Patient Monitor Market Size, Share & Trends Analysis by Device Type (Pulse Oximeters, Capnographs, Spirometers, Polysomnography (PSG) Devices, Peak Flow Meters, Gas Analyzers, and Others), By Technology (Wearable Respiratory Sensors, and Non-wearable/Table-top & Hand-held Devices), By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Diseases, and Others), By End-User (Hospitals & Clinics, Home-care Settings, Ambulatory Surgical Centers (ASCs), and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/respiratory-rate-patient-monitor-market
Regulatory Approvals Encouraging Adoption
- In November 2025, the FDA granted 510(k) clearance to the Hexoskin Medical System (HMS), marking a significant advancement in digital health. This smart shirt allows for long-term continuous monitoring of electrocardiogram (ECG) and respiratory signals in ambulatory patients, facilitating improved remote patient care and clinical trials in the US. It enables a comprehensive view of patient health rather than just short-term data snapshots.
- In June 2025, Mindset Medical received FDA 510(k) clearance for its contactless respiratory rate measurement device, the Informed Vital Core (IVC) App. This software-only medical device allows for respiratory rate measurement via smartphones, tablets, or laptop cameras. This clearance is Mindset Medical's second in less than a year, following a prior pulse rate measurement device clearance in November 2024. The IVC App enhances telehealth capabilities by enabling healthcare providers to collect physiological data without physical contact, supporting care delivery in various settings amid the growing adoption of telemedicine due to COVID-19.
- In November 2024, LifeSignals received FDA Class II 510(k) clearance for its UbiqVue 2A Multiparameter System, a cloud-based solution aimed at continuous patient monitoring in various healthcare settings. This system replaces traditional manual spot checking with real-time monitoring of multiple physiological parameters, such as SpO2, ECG, pulse rate, and more, enabling healthcare professionals to access vital signs remotely through a web portal. The UbiqVue 2A Biosensor, a single-use wearable device, securely transmits encrypted data to enhance patient safety and integrate seamlessly into existing healthcare workflows.
Market Coverage
- The market number available for – 2025-2035
- Base year- 2025
- Forecast period- 2026-2035
- Segment Covered-
- By Device Type
- By Technology
- By Indication
- By End User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape - GE HealthCare, Koninklijke Philips N.V., Masimo Corp., Medtronic plc, ResMed Inc.
Key questions addressed by the report.
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Respiratory Rate Patient Monitor Market Report Segment
By Device Type
- Pulse Oximeters
- Capnographs
- Spirometers
- Polysomnography (PSG) Devices
- Peak Flow Meters
- Gas Analyzers
- Others
By Technology
- Wearable Respiratory Sensors
- Non-wearable/Table-top & Hand-held Devices
By Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Sleep Apnea
- Infectious Diseases
- Others (Acute Respiratory Distress Syndrome, Pulmonary Hypertension)
By End-User
- Hospitals & Clinics
- Home-care Settings
- Ambulatory Surgical Centers (ASCs)
- Others (Laboratories, Emergency Medical Services)
Global Respiratory Rate Patient Monitor Market Report Segment by Region
North America
Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia and New Zealand
- ASEAN Economies
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/respiratory-rate-patient-monitor-market